License Agreement [Line Items]

No definition available.

Name:	jazz_LicenseAgreementLineItems
Namespace Prefix:	jazz_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Number Of Programs Eligible To Receive Regulatory And Commercial Milestone Payments

+ References

No definition available.

+ Details

Name:	jazz_NumberOfProgramsEligibleToReceiveRegulatoryAndCommercialMilestonePayments
Namespace Prefix:	jazz_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Research And Development Arrangement Upfront Payment Obligation

+ References

No definition available.

+ Details

Name:	jazz_ResearchAndDevelopmentArrangementUpfrontPaymentObligation
Namespace Prefix:	jazz_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Sale of Productive Asset, Percent Of Post-Tax Proceeds Entitled

+ References

No definition available.

+ Details

Name:	jazz_SaleOfProductiveAssetPercentOfPostTaxProceedsEntitled
Namespace Prefix:	jazz_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount, before accumulated amortization, of finite-lived intangible asset. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482558/350-40-50-1

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Name Accounting Standards Codification
-Section 55
-Paragraph 40
-SubTopic 30
-Topic 350
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482640/350-30-55-40

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 10
-Name Accounting Standards Codification
-Section S45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482665/350-30-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 928
-SubTopic 340
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478859/928-340-50-1

+ Details

Name:	us-gaap_FiniteLivedIntangibleAssetsGross
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Amount of gain (loss) on sale or disposal of other assets.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-28

+ Details

Name:	us-gaap_GainLossOnSaleOfOtherAssets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 12
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-12

+ Details

Name:	us-gaap_ProceedsFromSaleOfProductiveAssets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of writeoff for research and development asset acquired in transaction other than business combination or from joint venture formation or both. Includes, but is not limited to, software to be sold, leased, or marketed.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 985
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481283/985-20-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482665/350-30-50-1

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 730
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482916/730-10-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476148/220-40-50-21

+ Details

Name:	us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	srt_CounterpartyNameAxis=jazz_AbCelleraMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ContingentConsiderationByTypeAxis=jazz_UpfrontPaymentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ContingentConsiderationByTypeAxis=jazz_PotentialMilestonePaymentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=jazz_WerewolfMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Collaboration and License Agreement, Asset Purchase Agreement and Disposition (Details) $ in Millions	1 Months Ended		3 Months Ended		6 Months Ended
	Jun. 30, 2026 USD ($) program	Jan. 31, 2026 USD ($)	Jun. 30, 2026 USD ($)	Jun. 30, 2025 USD ($)	Jun. 30, 2026 USD ($)	Jun. 30, 2025 USD ($)	Dec. 31, 2025 USD ($)
License Agreement [Line Items]
Acquired in-process research and development			$ 77.0	$ 905.4	$ 77.0	$ 905.4
Potential milestone payment amount	$ 8,078.1		8,078.1		8,078.1		$ 8,210.1
Cash consideration		$ 200.0
Percentage of post-tax proceeds entitled		50.00%
Gain on sale of priority review voucher			0.0	$ 0.0	(122.8)	$ 0.0
AbCellera
License Agreement [Line Items]
Upfront payment obligation	28.0
AbCellera \| Upfront Payment
License Agreement [Line Items]
Acquired in-process research and development	$ 56.0
Number of research programs \| program	2
AbCellera \| Potential Milestone Payment
License Agreement [Line Items]
Potential milestone payment amount	$ 792.0		792.0		792.0
Werewolf \| Upfront Payment
License Agreement [Line Items]
Acquired in-process research and development			21.0		21.0
Werewolf \| Potential Milestone Payment
License Agreement [Line Items]
Potential milestone payment amount	$ 2.0		$ 2.0		$ 2.0